
Selected A-share announcements | CEB Bank plans to approve a comprehensive credit limit of 29 billion yuan for CITIC FAMC

CEB Bank announced that it plans to approve a comprehensive credit limit of 29 billion yuan for CITIC Financial Asset Management Co., Ltd., with a term of 12 months, constituting a related party transaction. CITIC Financial Asset holds 8.02% of CEB Bank's shares and has dispatched one director
Today's Focus
1. CEB Bank: Plans to approve a comprehensive credit limit of RMB 29 billion for CITIC Financial Assets
CEB Bank (601818.SH) announced that it plans to approve a comprehensive credit limit of RMB 29 billion for CITIC Financial Asset Management Co., Ltd., with a term of 12 months and a credit method. CITIC Financial Assets holds 8.02% of CEB Bank's shares and has dispatched one director, making it a major shareholder. This transaction constitutes a related party transaction.
2. New China Life Insurance: Net profit for the first three quarters expected to increase by 45%-65% year-on-year
New China Life Insurance (601336.SH) announced that it expects the net profit attributable to the parent company's shareholders for the first three quarters of 2025 to be between RMB 29.986 billion and RMB 34.122 billion, representing a year-on-year increase of 45% to 65%. The growth in performance is mainly due to the company's deepening reform and development, enhancing the value and operational quality of its insurance business, promoting the transformation of dividend insurance, and optimizing asset allocation, with investment income continuing to grow significantly compared to the same period last year.
3. Salt Lake Industry: Net profit for the third quarter expected to increase by 97%-141% year-on-year, driven by rising potassium chloride prices
Salt Lake Industry (000792.SZ) announced that it expects the net profit attributable to the shareholders of the listed company for the first three quarters of 2025 to be between RMB 4.3 billion and RMB 4.7 billion, an increase of 36.89% to 49.62% compared to the same period last year. The net profit attributable to the shareholders of the listed company for the third quarter is expected to be between RMB 1.8 billion and RMB 2.2 billion, an increase of 97.41% to 141.28% year-on-year. During the reporting period, the price of potassium chloride rose compared to the same period last year, driving profit growth; although the market price of lithium carbonate declined, the company's overall performance still achieved year-on-year growth.
4. Northern Rare Earth: Received a warning letter from the Inner Mongolia Securities Regulatory Bureau for undisclosed non-operating fund occupation by related parties
Northern Rare Earth (600111.SH) announced that it received a warning letter from the Inner Mongolia Securities Regulatory Bureau on October 13. The warning letter pointed out that from February 2019 to December 2024, the company's subsidiary, Baotou Steel Group Energy Conservation and Environmental Protection Technology Industry Co., Ltd., cumulatively issued wages, welfare expenses, insurance fees, etc., totaling RMB 8.9485 million to Inner Mongolia Baolan Environmental Protection New Materials Co., Ltd., constituting non-operating fund occupation by related parties. As of December 31, 2024, Baolan Environmental Protection Company has fully repaid the above-mentioned funds. The company failed to fulfill its information disclosure obligations regarding this matter, violating relevant regulations. The Inner Mongolia Securities Regulatory Bureau decided to take regulatory measures by issuing a warning letter to the company and recording it in the integrity file of the securities and futures market.
5. Yiyi Co., Ltd.: Planning to purchase a pet food company, stock suspended
Yiyi Co., Ltd. (001206.SZ) announced that it is planning to issue shares and pay cash to purchase assets and raise matching funds, with the target being Hangzhou Gao Ye Jia You Duo Duo Cat Pet Food Co., Ltd. The transaction method will involve issuing shares and paying cash while raising matching funds. The scope of the transaction counterparties has not yet been finalized, and the specific transaction method and plan will be subject to subsequent announcements. The company has signed a letter of intent with the main transaction counterparties, reaching a preliminary intention to purchase assets. The company's stock will be suspended from trading starting October 14, 2025, and it is expected to disclose the transaction plan within no more than 10 trading days 6. Chuangjiang New Materials: Net profit in the first three quarters is expected to increase by 2058%-2243% year-on-year
Chuangjiang New Materials (002171.SZ) released its performance forecast for the first three quarters of 2025, expecting a net profit attributable to shareholders of the listed company to be between 350 million and 380 million yuan, an increase of 2057.62%-2242.56% compared to the same period last year. During the reporting period, the company's product upgrades and technological transformation projects were put into production in an orderly manner, effectively driving the continuous growth of production and sales scale and operating income; at the same time, the company promoted product upgrades and refined management, enhancing product added value and core competitiveness.
7. Juchip Technology: Net profit in the first three quarters is expected to increase by 113% year-on-year, with sales revenue related to edge AI processor chips increasing several times
Juchip Technology (688049.SH) announced that it expects a net profit attributable to the parent company owners of 151 million yuan in the first three quarters of 2025, a year-on-year increase of 112.94%. In the third quarter, both sales and net profit achieved growth both sequentially and year-on-year, setting new historical peaks for the company's quarterly performance. During the reporting period, the promotion of edge AI audio chips based on the first-generation in-memory computing technology progressed smoothly, with multiple projects from several leading brands successfully initiated and set to enter mass production soon; edge AI processor chips were successfully applied in high-end speakers and Party speakers of leading audio brands, significantly increasing market penetration and achieving several times growth in related sales revenue. The company continues to iterate its chip products, committed to empowering various product lines with in-memory computing technology, and the R&D of ATW609X for the smart Bluetooth wearables field is progressing smoothly. The R&D work for the second-generation in-memory computing technology IP is also steadily advancing according to the established plan, aiming to achieve a multiple increase in the single-core NPU computing power of the next-generation chip, significantly improving the chip's energy efficiency ratio, and fully supporting Transformer models.
8. Fudan Zhangjiang: Application for marketing authorization of Obeticholic Acid Tablets for the treatment of primary biliary cholangitis not approved
Fudan Zhangjiang (688505.SH) announced that its wholly-owned subsidiary Taizhou Fudan Zhangjiang Pharmaceutical Co., Ltd. received a "Notice of Disapproval of Drug Marketing Application" issued by the National Medical Products Administration, stating that the Obeticholic Acid Tablets for the treatment of primary biliary cholangitis did not meet the relevant requirements for drug registration, and the registration application was not approved. The project has accumulated R&D investment of approximately 125 million yuan, which will not have a significant impact on the company's current financial status. The company will continue to increase R&D investment and accelerate the progress of ongoing projects. This drug is a generic drug for a conditionally approved drug overseas that has not been marketed domestically, and the reference formulation has not received regular approval abroad. Given the current lack of confirmed benefits from the research conclusions after the original drug's market launch, and the serious risks that cannot support the benefits of Obeticholic Acid for the indications approved abroad outweighing the risks, it is believed that the existing data cannot fully support the drug's conventional approval as a Class 3 generic drug.
9. Zhongshi Technology: Net profit in the first three quarters is expected to increase by 74%-104%, with an increase in the shipment volume of thermal materials and components Zhongshi Technology (300684.SZ) released its performance forecast for the first three quarters of 2025, expecting a net profit attributable to shareholders of the listed company to be between 230 million and 270 million yuan, an increase of 74.16%-104.45% compared to the same period last year. During the reporting period, the company benefited from the launch of new products and the ramp-up of new projects by major North American clients, leading to an increase in the shipment volume of thermal materials and components; the company continued to deepen cooperation with global leading clients, steadily increasing the penetration rate and market share of thermal products. The company has been actively promoting new thermal solutions and core product R&D in emerging consumer electronics and digital infrastructure (data centers, communication base stations, etc.) under AI empowerment, and is actively expanding its second growth curve. Revenue from efficient thermal modules, core thermal components, and high-performance thermal materials has grown rapidly year-on-year. At the same time, product structure optimization combined with cost reduction and efficiency enhancement has significantly improved the company's profitability.
Operating Performance
1. Feirongda: Net profit expected to increase by 111%-130% year-on-year in the first three quarters
Feirongda announced that it expects a net profit attributable to shareholders of the listed company to be between 275 million and 300 million yuan for the first three quarters of 2025, an increase of 110.80%-129.96% compared to the same period last year.
2. Zhongtong Bus: September sales increased by 36.88% year-on-year
Zhongtong Bus announced that its sales in September were 1,106 vehicles, an increase of 36.88% year-on-year; the cumulative sales for this year reached 9,010 vehicles, an increase of 5.49% year-on-year.
Repurchase & Increase/Decrease Holdings
1. Yuntian Lifa: Donghai Yuntian and Donghai Phase I reduced holdings by a total of 3.1702 million shares from September 24 to October 10
Yuntian Lifa announced that it received a notice from shareholders Donghai Yuntian and Donghai Phase I regarding the reduction of stock equity that reached the 1% threshold. From September 24, 2025, to October 10, 2025, Donghai Yuntian and Donghai Phase I reduced their holdings by a total of 3.1702 million shares through centralized bidding and block trading, reducing their shareholding ratio from 7.8697% to 6.9862%.
Major Contracts
1. Hanjian Heshan: Won a bid for a 207 million yuan land drainage project, accounting for approximately 26.29% of the audited revenue for 2024
Hanjian Heshan announced that it received a "Bid Notification" issued by the bidding agency, confirming that it won the bid for the "China Nuclear Construction CNNC Huaxing Infrastructure Division Land Drainage Project Reinforced Concrete Drainage Pipe Conventional Procurement (Section 1)" with a bid amount of 207 million yuan. The bid amount accounts for approximately 26.29% of the company's audited revenue for 2024.
*2. ST Weihai: Pre-bid for a 313 million yuan engineering construction project
*ST Weihai announced that on October 11, it learned that it was the candidate for the bid for the "Huaihe River Estuary Waterway Phase II Project (within Huai'an City) River Engineering Construction Section 14," with a bid price of 313 million yuan. The pre-bid amount accounts for 12.60% of the company's total audited revenue for 2024 This article is reproduced from Tencent Zixuan Stock, edited by Zhitong Finance: Chen Xiaoyi

